- Home
- XNCR vs NX Comparison
XNCR vs NX Comparison
Compare XNCR & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | NX |
|---|---|---|
| Founded | 1997 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 797.0M |
| IPO Year | 2013 | 2008 |
Fundamental Metrics
Financial Performance| Metric | XNCR | NX |
|---|---|---|
| Price | $11.64 | $16.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $22.89 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 579.8K | 493.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.84% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $125,576,000.00 | ★ $1,837,641,000.00 |
| Revenue This Year | N/A | $3.18 |
| Revenue Next Year | $6.52 | $2.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 13.65 | ★ 43.81 |
| 52 Week Low | $6.92 | $11.04 |
| 52 Week High | $18.69 | $22.90 |
Technical Indicators
Market Signals| Indicator | XNCR | NX |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 25.88 |
| Support Level | $11.02 | $16.09 |
| Resistance Level | $12.58 | $19.88 |
| Average True Range (ATR) | 0.88 | 0.88 |
| MACD | 0.02 | -0.69 |
| Stochastic Oscillator | 24.74 | 0.08 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.